
RARE Stock Price Prediction
Ultragenyx Pharmaceutical Inc
- Overview
- Forecast
- Valuation
- Earnings
1-Day-Price-Prediction
-3.14%
1-Week Prediction
+0.42%
Based on our advanced algorithm, we predict that RARE stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $28.04, while the 1-week outlook suggests a value of $29.07. For the 1-month forecast, we project a price of $31.85. Looking further ahead, our 2026 projection estimates a value of $51.38, with a long-term 2030 forecast reaching $120.58. Stay informed and make strategic decisions with our data-driven insights!
31.850
Should I Buy Ultragenyx Pharmaceutical Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RARE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
RARE stock price ended at $28.97 on Wednesday, after rising 3.06%
The Ultragenyx Pharmaceutical Inc stock price increased by 3.06% on the last trading day (13 Aug 2025), rising from 28.43 to 28.97. Throughout the last trading session, the stock experienced a fluctuation of 4.45% , ranging from a day low of $28.12 to a day high of 29.37. The price has declined in 4 of the last 10 days, resulting in a total change of 6.74% during this period. On the last day, trading volume decrease by 562.52K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.69M shares were traded, amounting to approximately 48.81M.
RARE Technical Signals
RARE(Ultragenyx Pharmaceutical Inc Corp) has 1 buy signal and 4 sell signals now. The current trend is consolidation starting from 2025-08-11. The total price change during this trend is +5.77%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of RARE over the last 5 trading days is 44.90M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
RARE Moving Average Analysis
Ultragenyx Pharmaceutical Inc's overall moving average trend leans more bullish as of Thursday, August 14, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $29.76, and $30.85. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $26.24, and $25.15. A break-down below any of these levels will issue sell signals.
RARE Short Selling Analysis
The short sale ratio of Ultragenyx Pharmaceutical Inc(RARE) as of 11 Aug 2025 is 16.83%, dropping from last trading day. With decreasing price from 27.54 to 27.39. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary

Sell
Sell
4
Buy
1
Moving Average
Swing

Stock Price Above SMA_5
Short Term

SMA_5 Above SMA_20
Mid Term

SMA_20 Below SMA_60
Long Term

SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
1.83
Bullish
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
180.259
Bearish
Awesome Oscillator (5, 34)
AO_5_34 < 0
-2.741
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-1.17
Bearish
Williams %R (14 days)
WILLR_14 > -20
-14.035
Bearish
RARE Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, Ultragenyx Pharmaceutical Inc (RARE) is anticipated to change hands in a trading channel between $34.14 and $58.73.
Ultragenyx Pharmaceutical Inc Stock Forecast 2026
Jan 2026: RARE Stock Forecast
Potential ROI: 7.78%
In Jan 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $40.34. The price is predicted to fluctuate between a low of $35.99 and a high of $47.58.
Feb 2026: RARE Stock Forecast
Potential ROI: 30.78%
In Feb 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $48.95. The price is predicted to fluctuate between a low of $42.22 and a high of $56.96.
Mar 2026: RARE Stock Forecast
Potential ROI: 6.39%
In Mar 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $39.82. The price is predicted to fluctuate between a low of $34.50 and a high of $42.84.
Apr 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Apr 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $51.68 and a high of $58.73.
May 2026: RARE Stock Forecast
Potential ROI: 34.70%
In May 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $50.42. The price is predicted to fluctuate between a low of $40.42 and a high of $58.33.
Jun 2026: RARE Stock Forecast
Potential ROI: 14.61%
In Jun 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $42.90. The price is predicted to fluctuate between a low of $34.14 and a high of $50.25.
Jul 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Jul 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $47.44 and a high of $57.99.
Aug 2026: RARE Stock Forecast
Potential ROI: 37.26%
In Aug 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.38. The price is predicted to fluctuate between a low of $48.46 and a high of $55.27.
Sep 2026: RARE Stock Forecast
Potential ROI: 11.67%
In Sep 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $41.80. The price is predicted to fluctuate between a low of $37.62 and a high of $47.67.
Oct 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Oct 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $43.78 and a high of $56.68.
Nov 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Nov 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $50.96 and a high of $51.97.
Dec 2026: RARE Stock Forecast
Potential ROI: 32.87%
In Dec 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $49.73. The price is predicted to fluctuate between a low of $49.40 and a high of $52.29.
RARE Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Ultragenyx Pharmaceutical Inc(RARE), our algorithm predicts RARE's 1-month price at $18.48, with an -32.91%downwardshift. Using a similarity score up to 98.86%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Ultragenyx Pharmaceutical Inc (RARE.O) stock, as of Sunday, August 10, 2025 , forecasts a -32.91% change over the next month, based on its high correlation with ACHV.O stock patterns. The similarity between their price movements over the analyzed periods is 98.86%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

RARE
Future prediction
Up: -32.91%


Full Access. No Commitment.
7 Days Free!
AI Stock Picker
AI Swing Trade Signal
AI Earning Prediction
AI Screener
AI Financial Agent Help You Do Research
Already have an account? Sign In Here

ACHV
Down: -32.91%Similarity: 98.86%
Name
Similarity
Up/Down

ACHV.O
98.86%
-32.91%

TDTH.O
98.79%
+10.51%

FTRK.O
98.75%
-29.11%

SJ.O
98.73%
+15.48%

CSCO.O
98.72%
+7.87%

JRVR.O
98.62%
+3.11%

CAR.O
98.62%
+6.68%

NTCT.O
98.59%
+10.01%

NERV.O
98.57%
-18.55%

CMG.N
98.53%
+14.80%
RARE Seasonality Analysis
Based on RARE's historical stock price data across all years, the probability of a positive return in August is54.55%, suggesting it maybe an ideal month to invest in RARE. In contrast,Juneoffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in June has the highest probability of a positive return (72.73%), while September has the lowest probability (10.00%).
Performance Seasonality
The chart shows Ultragenyx Pharmaceutical Inc. (RARE)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch

AAPL
Apple Inc
233.330
USD
+1.60%

TSLA
Tesla Inc
339.380
USD
-0.43%

NVDA
NVIDIA Corp
181.590
USD
-0.86%

MSFT
Microsoft Corp
520.580
USD
-1.64%

META
Meta Platforms Inc
780.080
USD
-1.26%

GOOGL
Alphabet Inc
201.960
USD
-0.68%

AMZN
Amazon.com Inc
224.560
USD
+1.40%

WMT
Walmart Inc
100.990
USD
-2.54%

AVGO
Broadcom Inc
309.090
USD
-1.20%

GOOG
Alphabet Inc
203.030
USD
-0.55%
FAQ

Should I buy Ultragenyx Pharmaceutical Inc (RARE.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RARE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.

Which months have the highest win rate for buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in a year?

How has Ultragenyx Pharmaceutical Inc. (RARE)'s stock price performed over the past three years?

Which bull technical signals does RARE have?

Which bearish technical signals does RARE have?

Is RARE a buy based on overall technical signals summary?

What is the trend of Ultragenyx Pharmaceutical Inc (RARE)'s moving average?

What is price prediction for RARE stock next month?

What is price prediction 2025 for RARE Stock?
